Pulmonary hypertension and cor pulmonale in COPD

Seminars in Respiratory and Critical Care Medicine

Volumn 24, Issue 3, 2003, Pages 263-272

  Lee Chiong Jr , Teofilo L ^a   Matthay, Richard A ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic obstructive pulmonary disease; Cor pulmonale; Left ventricle; Pulmonary artery hypertension; Right ventricle

Indexed keywords

ALMITRINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMRINONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; INOTROPIC AGENT; METHYLDOPA; NITRIC ACID DERIVATIVE; NITRIC OXIDE; OXYGEN; PHENTOLAMINE; PRAZOSIN; PROSTACYCLIN; PROSTAGLANDIN E1; SALBUTAMOL; TERBUTALINE; THEOPHYLLINE; URAPIDIL; VASODILATOR AGENT;

ANAMNESIS; ARTERIAL OXYGEN TENSION; ARTERY CATHETERIZATION; ATTENUATION; BLOOD VISCOSITY; BREATHING MECHANICS; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COR PULMONALE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EVALUATION; HEART RIGHT VENTRICLE DYSPLASIA; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HUMAN; HYPERCAPNIA; HYPOTENSION; LUNG BLOOD VESSEL; LUNG GAS EXCHANGE; LUNG VASCULAR RESISTANCE; METABOLIC ALKALOSIS; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOSTATIC HYPOTENSION; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RADIOISOTOPE VENTRICULOGRAPHY; REVIEW; SIDE EFFECT; SPIROMETRY; SURVIVAL; SYMPTOMATOLOGY; THORAX RADIOGRAPHY;

EID: 0038675371     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-41087     Document Type: Review

References (89)

1. Lee-Chiong TL, Matthay RA. The heart in the stable COPD patient. In: Similowski T, Whitelaw WA, Derenne JP, eds. Clinical Management of Chronic Obstructive Pulmonary Disease. New York: Marcel Dekker; 2002:475-532
2. Lee-Chiong TL, Matthay RA. COPD and the left heart. In: Similowski T, Whitelaw WA, Derenne JP, eds. Clinical Management of Chronic Obstructive Pulmonary Disease. New York: Marcel Dekker; 2002:533-547
3. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease, Part One. Am J Respir Crit Care Med 1994;150:833-852
4. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease, Part Two. Am J Respir Crit Care Med 1994;150:1158-1168
5. Wiedemann HP, Matthay RA. Cor pulmonale. In: Braunwald E, ed. Heart Disease. A Textbook of Cardiovascular Medicine. 5th ed. Philadelphia: WB Saunders; 1997:1604-1625
6. World Health Organization. Chronic cor pulmonale: a report of the expert committee. Circulation 1963;27:594-598
7. Ben Jrad I, Slimane ML, Boujnah MR, Ben Hamda K, Ameur Y. Prognosis and treatment of chronic cor pulmonale. Tunis Med 1993;71:505-508
8. Heath D, Brewer D, Hicken P. Mechanisms and pathology. In: Thomas CC, ed. Cor pulmonale in Emphysema. Springfield: Thomas; 1968:1-37
9. Mitchell RS, Vincent TN, Filley GF. Chronic obstructive bronchopulmonary disease, IV: The clinical and physiological differential of chronic bronchitis and emphysema. Am J Med Sci 1964;247:513-517
10. Renzetti AD Jr, McClement JH, Litt BD. The Veterans Administration cooperative study of pulmonary function, III: Mortality in relation to respiratory function in chronic obstructive pulmonary disease. Am J Med 1966;41:115-119
11. Laks MM, Garner D, Swan HJC. Volumes and compliances measured simultaneously in the right and left ventricles of the dog. Circ Res 1967;20:565-569
12. Khaja F, Parker JO. Right and left ventricular performance in chronic obstructive lung disease. Am Heart J 1971;82:319-327
13. MacNee W. Right ventricular function in cor pulmonale. Cardiology 1988;75(suppl 1):S30-S40
14. Matthay RA, Arroliga AC, Wiedemann HP, Schulman DS, Mahler DA. Right ventricular function at rest and during exercise in chronic obstructive pulmonary disease. Chest 1992; 101(suppl 5):S225-S262
15. Mizushige K, Morita H, Senda S, Matsuo H. Influence of right ventricular pressure overload on left and right ventricular filling in cor pulmonale assessed with Doppler echocardiography. Jpn Circ J 1989;53:1287-1296
16. Heath D, Du Shane JW, Wood EH, Edwards JE. Structure of the pulmonary trunk at different ages and in cases of pulmonary hypertension and pulmonary stenosis. J Pathol Bacteriol 1959;77:443-456
17. Weibel ER, Gomez DM. The architecture of the human lung. Science 1962;137:577-585
18. Harris P, Heath D. Normal variations in pressure and flow. In: Harris P, Heath D, eds. The Human Pulmonary Circulation. 3rd ed. Edinburgh: Churchill Livingstone; 1986:149-160
19. Riley RL, Himmelstein A, Morley HL, Motley HL, Weiner HM, Cournand A. Studies of the pulmonary circulation at rest and during exercise in normal individuals and in patients with chronic pulmonary disease. Am J Physiol 1948;152:372-382
20. Abel RL. Effects of alterations in peripheral resistance on left ventricular function. Proc Soc Exp Biol Med 1965;120:52-56
21. Murphy ML, Adamson J, Hutcheson F. Left ventricular hypertrophy in patients with chronic bronchitis and emphysema. Ann Intern Med 1974;81:307-313
22. Fluck DC, Chandrasekar RG, Gardner FV. Left ventricular hypertrophy in chronic bronchitis. Br Heart J 1966;28:92-97
23. Robotham JL, Lixfeld W, Holland L, MacGregor D, Bryan AC, Rabson J. Effects of respiration on cardiac performance. J Appl Physiol 1978;44:703-709
24. Harvey RM, Ferrer MI, Richards DW, Cournand A. Influence of chronic pulmonary disease on the heart and circulation. Am J Med 1951;10:719-738
25. Dunnill MS. Fibrinoid necrosis in the branches of the pulmonary artery and chronic nonspecific lung disease. Br J Dis Chest 1960;54:355-360
26. Harris P, Heath D. The pulmonary vasculature in emphysema. In: Harris P, Heath D, eds. The human pulmonary circulation. Edinburgh: Churchill Livingstone; 1986:507-521
27. Enson Y, Guintini C, Lewis ML, Morris TQ, Ferrer MI, Harvey RM. The influence of hydrogen ion concentration and hypoxia on the pulmonary circulation. J Clin Invest 1964; 43:1146-1162
28. Durand J, Leroy-Ladurie M, Ransom-Bitker B. Effects of hypoxia and hypercapnia on the repartition of pulmonary blood flow in supine subjects. Respir Res 1970;5:156-165
29. Dinh-Xuan AT, Higenbottam TW, Wallwork J. Relationship between chronic hypoxia and in vitro pulmonary relaxation mediated by endothelium-derived relaxing factors in human chronic obstructive lung disease. Angiology 1992;43:350-356
30. Cargill RI, Kiely DG, Clark RA, Lipworth BJ. Hypoxaemia and release of endothelin-1. Thorax 1995;50:1308-1310
31. Moncada S, Palmer RMJ, Higgs EA. Prostacyclin and endothelial-derived relaxing factor: biological interactions and significance. In: Verstraete M, Verrmylen J, Lijnen RH, eds. Thrombosis and Haemostasis. Belgium: University Press Leuven, 1987:597-618
32. Clini E, Cremona G, Campana M, et al. Production of endogenous nitric oxide in chronic obstructive pulmonary disease and patients with cor pulmonale. Correlates with echo-Doppler assessment. Am J Respir Crit Care Med 2000;162:446-450
33. Segel N, Bishop JM. The circulation in patients with chronic bronchitis and emphysema at rest and during exercise with special reference to the influence of change in blood viscosity and blood volume on the pulmonary circulation. J Clin Invest 1966;45:1555-1568
34. Harris P, Segel N, Green J, Housley E. The influence of the airways resistance and alveolar pressure on the pulmonary resistance in chronic bronchitis. Cardiovasc Res 1968;2:84-94
35. Morpurgo M. Noninvasive assessment of pulmonary arterial hypertension in chronic lung disease (WHO study). Eur Respir J 1989;2:S666-S668
36. Hill NS, The cardiac exam in lung disease. Clin Chest Med 1987;8:273-285
37. Matthay RA, Schwarz MI, Ellis JH, et al. Pulmonary artery hypertension in chronic obstructive pulmonary disease: determination by chest radiography. Invest Radiol 1981;16:95-100
38. Kilcoyne MM, Davis AL, Ferrer MI. A dynamic electrocardiographic concept useful in the diagnosis of cor pulmonale. 1970;42:903
39. Incalzi RA, Fuso L, De Rosa M, et al. Electrocardiographic signs of chronic cor pulmonale: a negative prognostic finding in chronic obstructive pulmonary disease. Circulation 1999; 99:1600-1605
40. Himelman RB, Struve SN, Brown JK, Namnum P, Schiller NB. Improved recognition of cor pulmonale in patients with severe chronic obstructive pulmonary disease. Am J Med 1988;84:891-898
41. Matthay RA, Berger HJ. Noninvasive assessment of right and left ventricular function in acute and chronic respiratory failure. Crit Care Med 1983;11:329-338
42. Himelman RB, Stulbarg K, Kircher B, et al. Noninvasive evaluation of pulmonary arterial pressure during exercise by saline enhanced Doppler echocardiography in chronic pulmonary disease. Circulation 1989;79:863-871
43. Starling MR, Crawford MH, Sorensen SG, O'Rourke RA. Two-dimensional echocardiographic technique evaluating right ventricular size and performance in patients with obstructive lung disease. Circulation 1982;66:612-620
44. Zompatori M, Battaglia M, Rimondi MR, Battista G, Stambazzi C. Hemodynamic estimation of chronic cor pulmonale by Doppler echocardiography: clinical value and comparison with other noninvasive imaging techniques. Rays 1997;22:73-93
45. Berger HJ, Matthay RA, Loke J, Marshal RC, Gottschalk A, Zaret BL. Assessment of cardiac performance with quantitative radionuclide angiography: right ventricular ejection fraction with reference to findings in chronic obstructive pulmonary disease. Am J Cardiol 1978;41:897-905
46. Maddahi J, Bermon DS, Matsuoka DT, et al. A new technique for assessing right ventricular ejection fraction using rapid multiple gated equilibrium cardiac blood pool scintigraphy. Circulation 1979;60:581-589
47. Kato H, Misawa T, Kutsumi Y, et al. Quantitative evaluation of right ventricular overload in cor pulmonale using 201TI myocardial SPECTJ Cardiology 1990;20:167-175
48. Longmore DB, Klipstein RH, Underwood SR, et al. Dimensional accuracy of magnetic resonance studies of the heart. Lancet 1985;1:1360-1362
49. Turnbull LW, Ridgeway JP, Biernacki W, et al. Assessment of the right ventricle by magnetic resonance imaging in chronic obstructive lung disease. Thorax 1990;45:597-601
50. British Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating bronchitis and emphysema. Lancet 1981;1:681-685
51. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann Intern Med 1980;93:391-398
52. Timms RM, Khaja FU, Williams GW. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. Ann Intern Med 1985;102:29-36
53. Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Pelletier A. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1985;131: 493-498
54. Ashutosh K, Mead G, Dunsky M. Early effects of oxygen administration and prognosis in chronic obstructive pulmonary disease and cor pulmonale. Am Rev Respir Dis 1983;127: 399-404
55. MacNee W, Wathen CG, Flenley DC, Muir AD. The effects of controlled oxygen therapy on ventricular function in patients with stable and decompensated cor pulmonale. Am Rev Respir Dis 1988;137:1289-1295
56. Wiedemann HP, Matthay RA. Cor pulmonale in chronic obstructive pulmonary disease: circulatory pathophysiology and new concepts of therapy. In: Simmons DH, ed. Current Pulmonology. Vol 8. Chicago: Year Book Medical Publishers; 1987:127-162
57. Bardsley PA, Tweney J, Morgan N, Howard P. Oral almitrine in treatment of acute respiratory failure and cor pulmonale in patients with an exacerbation of chronic obstructive airways disease. Thorax 1991;46:493-498
58. Melot C, Naeije R, Rothschild T, Mertens P, Mols P, Hallemans R. Improvement in ventilation-perfusion matching by almitrine in COPD. Chest 1983;83:528-533
59. Connaughton JJ, Douglas NJ, Morgan AD, et al. Almitrine improves oxygenation when both awake and asleep in patients with hypoxia and carbon dioxide retention caused by chronic bronchitis and emphysema. Am Rev Respir Dis 1985;132:206-210
60. Adnot S, Samoyeau R, Weitzenblum E. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil. Blood Press 1995;3:47-57
61. Van Mieghem W, De Backer G, De Wispelaere B, Billiet L, Cosemans J. Phentolamine infusion in cor pulmonale due to chronic obstructive pulmonary disease. Acta Cardiologica 1978;33:253-262
62. Vik-Mo H, Walde N, Jentoft H, Halvorsen FJ. Improved haemodynamics but reduced arterial blood oxygenation, at rest and during exercise after long-term oral prazosin therapy in chronic cor pulmonale. Eur Heart J 1985;6:1047-1053
63. Van Mieghem W, Van den Brande P, De Waele R, Meirghaeghe J, Arens M, Demedts M. Evaluation of the safety and efficacy of amrinone in chronic obstructive lung disease with cor pulmonale. Acta Cardiologica 1990;1:57-64
64. Stockley RA, Finnegan P, Bishop JM. Effect of intravenous terbutaline on arterial blood gas tensions, ventilation, and pulmonary circulation in patients with chronic bronchitis and cor pulmonale. Thorax 1977;32:601-605
65. Chan CK, Loke J, Snyder PE, Wackers F, Mattera J, Matthay RA. Oral terbutaline augments cardiac performance in chronic obstructive pulmonary disease. Am J Med Sci 1988;296:33-38
66. Mols P, Ham H, Naeije N, et al. How does salbutamol improve the ventricular performance in patients with chronic obstructive pulmonary disease? J Cardiovasc Pharmacol 1988;12:127-133
67. Mathur PN, Powles AC, Pugsley SO, McEwan MP, Campbell EJ. Effect of long-term administration of digoxin on exercise performance in chronic airflow limitation. Eur J Respir Dis 1985;66:273-283
68. Heinman HO. Right-sided heart failure and the use of diuretics. Am J Med 1978;64:357-370
69. Evans TW, Waterhouse J, Finlay M, Suggett AJ, Howard P. The effects of long-term methyldopa in patients with hypoxic cor pulmonale. Br J Dis Chest 1988;82:405-413
70. Germann P, Ziesche R, Leitner C, et al. Addition of nitric oxide to oxygen improves cardiopulmonary function in patients with severe COPD. Chest 1998;114:29-35
71. 1 in decompensated chronic obstructive pulmonary disease. Am Rev Respir Dis 1982;125:1-5
72. Jones K, Higgenbottam T, Wallwork J. Pulmonary vasodilation and prostacyclin in primary and secondary pulmonary hypertension. Chest 1989;96:784-789
73. Matthay RA. Favorable cardiovascular effects of theophylline in COPD. Chest 1987;92(suppl 1):S22-S26
74. Matthay RA. Effects of theophylline on cardiovascular performance in chronic obstructive pulmonary disease. Chest 1985;88(suppl 2):S112-S117
75. Matthay RA, Berger HJ, Davies R, Gottschalk A, Zaret BL. Improvement in cardiac performance by oral long-acting theophylline in chronic obstructive pulmonary disease. Am Heart J 1982;104:1022-1026
76. Howard P. Vasodilator drugs in chronic obstructive airways disease. Eur Respir J 1989;7:678-681
77. Saadjian A, Philip-Joet F, Arnaud A. Hemodynamic and oxygen delivery responses to nifedipine in pulmonary hypertension secondary to chronic obstructive lung disease. Cardiology 1987;74:196-204
78. Mookherjee S, Ashutosh K, Dunsky M, et al. Nifedipine in chronic cor pulmonale: acute and relatively long-term effects. Clin Pharmacol Ther 1988;44:289-296
79. Konietzko N, Schlehe H, Harich B, Matthys H. Effect of isosorbide dinitrate on hemodynamics and respiration of patients with coronary artery disease and of patients with chronic cor pulmonale. Respiration 1975;32:368-377
80. McGoon MD, Seward JB, Vlietstra RE, Choo MH, Moyer TP, Reeder GS. Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension. Br Heart J 1983;50:579-585
81. Zielinski J, Hawrylldewicz I, Gorecka D, Gluskowski J, Koscinska M. Captopril effects on pulmonary and systemic hemodynamics in chronic cor pulmonale. Chest 1986;90:562-565
82. Weisse AB, Mochos CB, Frank MJ, Levinson GE, Canilla JE, Regan TJ. Hemodynamic effect of staged hematocrit reduction in patients with stable cor pulmonale and severely elevated hematocrit levels. Am J Med 1975;58:92-98
83. Borst MM, Leschke M, Konig U, Worth H. Repetitive hemodilution in chronic obstructive pulmonary disease and pulmonary hypertension: effects on pulmonary hemodynamics, gas exchange, and exercise capacity. Respiration 1999;66:225-232
84. Bishop JM, Cross KW. Physiological variables and mortality in patients with various categories of chronic respiratory disease: WHO multicenter study. Bull Eur Physiopathol Respir 1984;20:495-500
85. Weitzenblum E, Sautejeau A, Ehrhart M, Mammosser M, Pettetier A. Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis 1984;130:993-998
86. Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981;1:681-686
87. Schrijen F, Uffholtz H, Polu JM, Poincelot F. Pulmonary and systemic hemodynamic evaluation in chronic bronchitis. Am Rev Respir Dis 1978;117:25-31
88. Weitzenblum E, Hirth C, Duculone A, Mirhom R, Rasaholinjanahary J, Ehrhart M. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981;36:752-758
89. Finlay M, Middleton HC, Peake MD, Howard P. Cardiac output, pulmonary hypertension, hypoxaemia and survival in patients with chronic obstructive airways disease. Eur J Respir Dis 1983;64:252-263